Abivax Profit Margin

The latest profit margin for ABVX is -24342.08% as of June 2026. That compares with -6744.83% in the prior-year period — down 260.9% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside Abivax's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABVX's profit margin moved from -6744.83% to -24342.08% — a 260.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abivax's valuation or profitability profile.

Against Healthcare companies, ABVX currently prints -24342.08% for profit margin, while the sector average sits near 9.71%. That is roughly 250894.3% below the sector mean. Large gaps often invite a closer look at Abivax's growth, margins, and balance sheet.

Profit Margin shows how effectively Abivax converts resources into returns. At -24342.08%, ABVX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6744.83% in the prior-year period — down 260.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ABVX's profit margin (-24342.08%), review year-over-year change from -6744.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.